Global Capecitabine Market Research Report 2020

Publisher Name :
Date: 02-Jan-2020
No. of pages: 93
Inquire Before Buying

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.

Capecitabine is a prescription medication used to treat breast cancer and cancer of the colon or rectum. Capecitabine belongs to a group of drugs called antimetabolites which work by interfering with DNA production, stopping cells from multiplying. The medication comes in tablet form and is usually taken twice daily, within 30 minutes after the end of a meal. The proportion of breast cancer with Handle in 2016 is about 40%, and the proportion of colorectal cancer in 2016 is about 31.94%.

The global Capecitabine market is valued at 1043 million US$ in 2020 is expected to reach 1013.8 million US$ by the end of 2026, growing at a CAGR of -0.4% during 2021-2026.

This report focuses on Capecitabine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Capecitabine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.

Market Segment Analysis

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Capecitabine market is segmented into

- 500 mg

- 150 mg

Segment by Application

- Breast Cancer

- Colorectal Cancer

- Stomach Cancer

Global Capecitabine Market: Regional Analysis

The Capecitabine market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Capecitabine market report are:

North America

- U.S.

- Canada

Europe

- Germany

- France

- U.K.

- Italy

- Russia

Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

Latin America

- Mexico

- Brazil

- Argentina

Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Capecitabine Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Capecitabine market include:

- Roche

- Teva

- Mylan

- Hikma

- Hengrui Medicine

- Cipla

- Reliance Group

- Hetero

Global Capecitabine Market Research Report 2020

Table of Contents
1 Capecitabine Market Overview
1.1 Product Overview and Scope of Capecitabine
1.2 Capecitabine Segment by Type
1.2.1 Global Capecitabine Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 500 mg
1.2.3 150 mg
1.3 Capecitabine Segment by Application
1.3.1 Capecitabine Sales Comparison by Application: 2020 VS 2026
1.3.2 Breast Cancer
1.3.3 Colorectal Cancer
1.3.4 Stomach Cancer
1.4 Global Capecitabine Market Size Estimates and Forecasts
1.4.1 Global Capecitabine Revenue 2015-2026
1.4.2 Global Capecitabine Sales 2015-2026
1.4.3 Capecitabine Market Size by Region: 2020 Versus 2026
2 Global Capecitabine Market Competition by Manufacturers
2.1 Global Capecitabine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Capecitabine Revenue Share by Manufacturers (2015-2020)
2.3 Global Capecitabine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Capecitabine Manufacturing Sites, Area Served, Product Type
2.5 Capecitabine Market Competitive Situation and Trends
2.5.1 Capecitabine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Capecitabine Players (Opinion Leaders)
3 Capecitabine Retrospective Market Scenario by Region
3.1 Global Capecitabine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Capecitabine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Capecitabine Market Facts & Figures by Country
3.3.1 North America Capecitabine Sales by Country
3.3.2 North America Capecitabine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Capecitabine Market Facts & Figures by Country
3.4.1 Europe Capecitabine Sales by Country
3.4.2 Europe Capecitabine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Capecitabine Market Facts & Figures by Region
3.5.1 Asia Pacific Capecitabine Sales by Region
3.5.2 Asia Pacific Capecitabine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Capecitabine Market Facts & Figures by Country
3.6.1 Latin America Capecitabine Sales by Country
3.6.2 Latin America Capecitabine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Capecitabine Market Facts & Figures by Country
3.7.1 Middle East and Africa Capecitabine Sales by Country
3.7.2 Middle East and Africa Capecitabine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Capecitabine Historic Market Analysis by Type
4.1 Global Capecitabine Sales Market Share by Type (2015-2020)
4.2 Global Capecitabine Revenue Market Share by Type (2015-2020)
4.3 Global Capecitabine Price Market Share by Type (2015-2020)
4.4 Global Capecitabine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Capecitabine Historic Market Analysis by Application
5.1 Global Capecitabine Sales Market Share by Application (2015-2020)
5.2 Global Capecitabine Revenue Market Share by Application (2015-2020)
5.3 Global Capecitabine Price by Application (2015-2020)
6 Company Profiles and Key Figures in Capecitabine Business
6.1 Roche
6.1.1 Corporation Information
6.1.2 Roche Description, Business Overview and Total Revenue
6.1.3 Roche Capecitabine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Roche Products Offered
6.1.5 Roche Recent Development
6.2 Teva
6.2.1 Teva Capecitabine Production Sites and Area Served
6.2.2 Teva Description, Business Overview and Total Revenue
6.2.3 Teva Capecitabine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Teva Products Offered
6.2.5 Teva Recent Development
6.3 Mylan
6.3.1 Mylan Capecitabine Production Sites and Area Served
6.3.2 Mylan Description, Business Overview and Total Revenue
6.3.3 Mylan Capecitabine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Mylan Products Offered
6.3.5 Mylan Recent Development
6.4 Hikma
6.4.1 Hikma Capecitabine Production Sites and Area Served
6.4.2 Hikma Description, Business Overview and Total Revenue
6.4.3 Hikma Capecitabine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Hikma Products Offered
6.4.5 Hikma Recent Development
6.5 Hengrui Medicine
6.5.1 Hengrui Medicine Capecitabine Production Sites and Area Served
6.5.2 Hengrui Medicine Description, Business Overview and Total Revenue
6.5.3 Hengrui Medicine Capecitabine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Hengrui Medicine Products Offered
6.5.5 Hengrui Medicine Recent Development
6.6 Cipla
6.6.1 Cipla Capecitabine Production Sites and Area Served
6.6.2 Cipla Description, Business Overview and Total Revenue
6.6.3 Cipla Capecitabine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Cipla Products Offered
6.6.5 Cipla Recent Development
6.7 Reliance Group
6.6.1 Reliance Group Capecitabine Production Sites and Area Served
6.6.2 Reliance Group Description, Business Overview and Total Revenue
6.6.3 Reliance Group Capecitabine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Reliance Group Products Offered
6.7.5 Reliance Group Recent Development
6.8 Hetero
6.8.1 Hetero Capecitabine Production Sites and Area Served
6.8.2 Hetero Description, Business Overview and Total Revenue
6.8.3 Hetero Capecitabine Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Hetero Products Offered
6.8.5 Hetero Recent Development
7 Capecitabine Manufacturing Cost Analysis
7.1 Capecitabine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Capecitabine
7.4 Capecitabine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Capecitabine Distributors List
8.3 Capecitabine Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Capecitabine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Capecitabine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Capecitabine by Type (2021-2026)
10.2 Capecitabine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Capecitabine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Capecitabine by Application (2021-2026)
10.3 Capecitabine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Capecitabine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Capecitabine by Region (2021-2026)
10.4 North America Capecitabine Estimates and Projections (2021-2026)
10.5 Europe Capecitabine Estimates and Projections (2021-2026)
10.6 Asia Pacific Capecitabine Estimates and Projections (2021-2026)
10.7 Latin America Capecitabine Estimates and Projections (2021-2026)
10.8 Middle East and Africa Capecitabine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Capecitabine Sales (Kg) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Capecitabine Sales (Kg) Comparison by Application: 2020 VS 2026
Table 3. Global Capecitabine Market Size by Type (Kg) (US$ Million) (2020 VS 2026)
Table 4. Global Key Capecitabine Manufacturers Covered in This Study
Table 5. Global Capecitabine Sales (Kg) by Manufacturers (2015-2020)
Table 6. Global Capecitabine Sales Share by Manufacturers (2015-2020)
Table 7. Global Capecitabine Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Capecitabine Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Capecitabine Average Price (USD/g) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Capecitabine Sales Sites and Area Served
Table 11. Manufacturers Capecitabine Product Types
Table 12. Global Capecitabine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Capecitabine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Capecitabine as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Capecitabine Players
Table 16. Global Capecitabine Sales (Kg) by Region (2015-2020)
Table 17. Global Capecitabine Sales Market Share by Region (2015-2020)
Table 18. Global Capecitabine Revenue (Million US$) by Region (2015-2020)
Table 19. Global Capecitabine Revenue Market Share by Region (2015-2020)
Table 20. North America Capecitabine Sales by Country (2015-2020) (Kg)
Table 21. North America Capecitabine Sales Market Share by Country (2015-2020)
Table 22. North America Capecitabine Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Capecitabine Revenue Market Share by Country (2015-2020)
Table 24. Europe Capecitabine Sales by Country (2015-2020) (Kg)
Table 25. Europe Capecitabine Sales Market Share by Country (2015-2020)
Table 26. Europe Capecitabine Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Capecitabine Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Capecitabine Sales by Region (2015-2020) (Kg)
Table 29. Asia Pacific Capecitabine Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Capecitabine Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Capecitabine Revenue Market Share by Region (2015-2020)
Table 32. Latin America Capecitabine Sales by Country (2015-2020) (Kg)
Table 33. Latin America Capecitabine Sales Market Share by Country (2015-2020)
Table 34. Latin America Capecitabine Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Capecitabine Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Capecitabine Sales by Country (2015-2020) (Kg)
Table 37. Middle East and Africa Capecitabine Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Capecitabine Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Capecitabine Revenue Market Share by Country (2015-2020)
Table 40. Global Capecitabine Sales (Kg) by Type (2015-2020)
Table 41. Global Capecitabine Sales Share by Type (2015-2020)
Table 42. Global Capecitabine Revenue (Million US$) by Type (2015-2020)
Table 43. Global Capecitabine Revenue Share by Type (2015-2020)
Table 44. Global Capecitabine Price (USD/g) by Type (2015-2020)
Table 45. Global Capecitabine Sales (Kg) by Application (2015-2020)
Table 46. Global Capecitabine Sales Market Share by Application (2015-2020)
Table 47. Global Capecitabine Sales Growth Rate by Application (2015-2020)
Table 48. Roche Capecitabine Corporation Information
Table 49. Roche Description and Business Overview
Table 50. Roche Capecitabine Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 51. Roche Main Product
Table 52. Roche Recent Development
Table 53. Teva Capecitabine Corporation Information
Table 54. Teva Corporation Information
Table 55. Teva Capecitabine Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 56. Teva Main Product
Table 57. Teva Recent Development
Table 58. Mylan Capecitabine Corporation Information
Table 59. Mylan Corporation Information
Table 60. Mylan Capecitabine Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 61. Mylan Main Product
Table 62. Mylan Recent Development
Table 63. Hikma Capecitabine Corporation Information
Table 64. Hikma Corporation Information
Table 65. Hikma Capecitabine Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 66. Hikma Main Product
Table 67. Hikma Recent Development
Table 68. Hengrui Medicine Capecitabine Corporation Information
Table 69. Hengrui Medicine Corporation Information
Table 70. Hengrui Medicine Capecitabine Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 71. Hengrui Medicine Main Product
Table 72. Hengrui Medicine Recent Development
Table 73. Cipla Capecitabine Corporation Information
Table 74. Cipla Corporation Information
Table 75. Cipla Capecitabine Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 76. Cipla Main Product
Table 77. Cipla Recent Development
Table 78. Reliance Group Capecitabine Corporation Information
Table 79. Reliance Group Corporation Information
Table 80. Reliance Group Capecitabine Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 81. Reliance Group Main Product
Table 82. Reliance Group Recent Development
Table 83. Hetero Capecitabine Corporation Information
Table 84. Hetero Corporation Information
Table 85. Hetero Capecitabine Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 86. Hetero Main Product
Table 87. Hetero Recent Development
Table 88. Sales Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Capecitabine Distributors List
Table 91. Capecitabine Customers List
Table 92. Market Key Trends
Table 93. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 94. Key Challenges
Table 95. Global Capecitabine Sales (Kg) Forecast by Type (2021-2026)
Table 96. Global Capecitabine Sales Market Share Forecast by Type (2021-2026)
Table 97. Global Capecitabine Revenue (Million US$) Forecast by Type (2021-2026)
Table 98. Global Capecitabine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 99. Global Capecitabine Sales (Kg) Forecast by Application (2021-2026)
Table 100. Global Capecitabine Revenue (Million US$) Forecast by Application (2021-2026)
Table 101. Global Capecitabine Sales (Kg) Forecast by Region (2021-2026)
Table 102. Global Capecitabine Sales Market Share Forecast by Region (2021-2026)
Table 103. Global Capecitabine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 104. Global Capecitabine Revenue Market Share Forecast by Region (2021-2026)
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Capecitabine
Figure 2. Global Capecitabine Sales Market Share by Type: 2020 VS 2026
Figure 3. 500 mg Product Picture
Figure 4. 150 mg Product Picture
Figure 5. Global Capecitabine Consumption Market Share by Application: 2020 VS 2026
Figure 6. Breast Cancer
Figure 7. Colorectal Cancer
Figure 8. Stomach Cancer
Figure 9. Global Capecitabine Market Size 2015-2026 (US$ Million)
Figure 10. Global Capecitabine Sales Capacity (Kg) (2015-2026)
Figure 11. Global Capecitabine Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Capecitabine Sales Share by Manufacturers in 2020
Figure 13. Global Capecitabine Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Capecitabine Revenue in 2019
Figure 15. Capecitabine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Capecitabine Sales Market Share by Region (2015-2020)
Figure 17. Global Capecitabine Sales Market Share by Region in 2019
Figure 18. Global Capecitabine Revenue Market Share by Region (2015-2020)
Figure 19. Global Capecitabine Revenue Market Share by Region in 2019
Figure 20. North America Capecitabine Sales Market Share by Country in 2019
Figure 21. North America Capecitabine Revenue Market Share by Country in 2019
Figure 22. U.S. Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 23. U.S. Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 25. Canada Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Capecitabine Sales Market Share by Country in 2019
Figure 27. Europe Capecitabine Revenue Market Share by Country in 2019
Figure 28. Germany Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 29. Germany Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 31. France Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 33. U.K. Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 35. Italy Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 37. Russia Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Capecitabine Sales Market Share by Region in 2019
Figure 39. Asia Pacific Capecitabine Revenue Market Share by Region in 2019
Figure 40. China Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 41. China Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 43. Japan Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 45. South Korea Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 47. India Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 49. Australia Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 51. Taiwan Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 53. Indonesia Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 55. Thailand Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 57. Malaysia Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 59. Philippines Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 61. Vietnam Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Capecitabine Sales Market Share by Country in 2019
Figure 63. Latin America Capecitabine Revenue Market Share by Country in 2019
Figure 64. Mexico Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 65. Mexico Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 67. Brazil Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 69. Argentina Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Capecitabine Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Capecitabine Revenue Market Share by Country in 2019
Figure 72. Turkey Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 73. Turkey Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 75. Saudi Arabia Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Capecitabine Sales Growth Rate (2015-2020) (Kg)
Figure 77. U.A.E Capecitabine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Capecitabine by Type (2015-2020)
Figure 79. Sales Market Share of Capecitabine by Type in 2019
Figure 80. Revenue Share of Capecitabine by Type (2015-2020)
Figure 81. Revenue Market Share of Capecitabine by Type in 2019
Figure 82. Global Capecitabine Sales Growth by Type (2015-2020) (Kg)
Figure 83. Global Capecitabine Sales Market Share by Application (2015-2020)
Figure 84. Global Capecitabine Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Capecitabine by Application (2015-2020)
Figure 86. Global Revenue Share of Capecitabine by Application in 2020
Figure 87. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Hikma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Hengrui Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Reliance Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Hetero Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Price Trend of Key Raw Materials
Figure 96. Manufacturing Cost Structure of Capecitabine
Figure 97. Manufacturing Process Analysis of Capecitabine
Figure 98. Capecitabine Industrial Chain Analysis
Figure 99. Channels of Distribution
Figure 100. Distributors Profiles
Figure 101. Porter's Five Forces Analysis
Figure 102. North America Capecitabine Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 103. North America Capecitabine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 104. Europe Capecitabine Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 105. Europe Capecitabine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 106. Latin America Capecitabine Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 107. Latin America Capecitabine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Middle East and Africa Capecitabine Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 109. Middle East and Africa Capecitabine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Asia Pacific Capecitabine Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 111. Asia Pacific Capecitabine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Bottom-up and Top-down Approaches for This Report
Figure 113. Data Triangulation
Figure 114. Key Executives Interviewed
  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs